Vanguard Capital Wealth Advisors Chimerix Inc Transaction History

Vanguard Capital Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$7.54 - $9.79 $93,375 - $121,239	-12,384 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$4.76 - $11.25 $49,104 - $116,055	-10,316 Reduced 45.44%	12,384 $119,000
Q4 2020 Jan 25, 2021	SELL	$2.43 - $5.42 $25,029 - $55,826	-10,300 Reduced 31.21%	22,700 $110,000
Q2 2020 Aug 05, 2020	BUY	$1.33 - $3.63 $43,890 - $119,790	33,000 New	33,000 $102,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.